All News

A patient with an abnormal PSA level transferred to another physician's care and was never told of his result. Two and a half years later, a biopsy revealed Gleason 9 prostate cancer.

Use of the urethral lift as a treatment for BPH provided rapid improvement in symptoms, flow, and quality of life that were sustained at 2 years in a multicenter study.

While questions and concerns about the use of advanced practice providers (APPs) in urology remain, the AUA's new consensus statement on the use of APPs provides a best practices framework for urology practices. Here are eight take-homes from the statement.

Advanced practice providers should be viewed as skilled members of a health care team who are filling a vital need, writes Urology Times Group Content Director Richard R. Kerr.

A large-scale study provides new evidence that targeted MRI ultrasound fusion prostate biopsy increases detection of high risk prostate cancers while decreasing detection of low-risk cancers. "More reliable diagnosis"

In this blog post, Dr. Henry Rosevear ponders the relationship between drug reps and urologists.

A newly published analysis “opens a huge opportunity for the discovery of new biomarkers” for multiple cancers, including aggressive prostate cancer, a leading urologic cancer expert says.

More than 90% of men whose lower urinary tract symptoms (LUTS) progress do not seek treatment for their symptoms, according to recent study results that one expert cautioned against overinterpreting.

Robot-assisted prolapse surgery for apical multicompartment vaginal prolapse repair is a safe procedure with durable outcomes, according to a retrospective study undertaken by urologists at Beaumont Hospital, Royal Oak, MI.

Urologists contacted by Urology Times do not expect the current makeup of Congress to have much of an impact on health care.

More work needs to be done to expand the role of minorities and women in urology leadership positions and to stay competitive with other specialties, Tracy M. Downs, MD, explains in this interview.

To make sure you enjoy your retirement without financial worries, you should ensure you have enough money saved based on your own unique situation.

If you feel like the practice of medicine is becoming more complicated and that the government and the payers are out to get you, you are not alone, nor are you paranoid. In this article, we examine a few of the issues you are currently facing and some of the choices you have to make.

In this article, Robert A. Dowling, MD, covers some practical aspects of telemedicine and what it might mean for urology.

While it is often difficult to defend a case involving the removal of an organ for cancer that is then determined to be cancer free, the added claim of lack of informed consent for the procedure does not aid the defense in these lawsuits.

A novel imaging technique may prove more effective than current magnetic resonance imaging approaches for localizing prostate tumors, researchers say.

A combination vaccine and androgen ablation therapy is showing promise in some patients with prostate cancer.

Get comprehensive coverage-including web-exclusive content and videos-on prostate cancer treatment and current controversies.

An advanced prostate cancer treatment protocol incorporating testosterone shows promise for treating the disease and reversing resistance to androgen deprivation therapy.

The FDA has approved ceftolozane/tazobactam (Zerbaxa) for the treatment of adults with complicated urinary tract infections.

Just over a year ago, the Office of Inspector General of the Department of Health and Human Services issued a report declaring that Medicare payments for vacuum erection systems were “grossly excessive” and recommended steps to remedy the situation.

Read and learn from Henry Rosevear, MD who experienced first hand how falls in the elderly are common and serious.

In this video, Edward Karpman, MD, shows how he performs microsurgical two-layer vasovasostomy to reconstruct the vas deferens after vasectomy.

In this video, Daniel H. Williams, IV, MD, demonstrates the use of microsurgical epididymovasostomy (two-suture intussusception technique) when no sperm are found in the testicular end of the vas deferens at the time of microsurgical reconstruction.

Urologists at the University of Southern California’s Institute of Urology in Los Angeles are taking robotic kidney surgery to a new level. Inderbir S. Gill, MD, MCh, executive director of the USC Institute of Urology, has pioneered the use of the robot in patients with complex (level III) inferior vena cava thrombi.

Advances in the diagnosis and treatment of prostate cancer are among the great medical accomplishments of the latter part of the 20th century and beginning of the 21st. Five-year survival rates for newly diagnosed loco-regional cancer advanced from 68% in 1975-’77 to 83% in 1987-’89 to nearly 100% in 2003-’09, according to the American Cancer Society. This victory, however impressive, is incomplete.

The addition of radiation treatment to hormone therapy reduces mortality in older men with locally advanced prostate cancer compared with hormone therapy alone, according to a recently published study in the Journal of Clinical Oncology.

A genomic test for prostate cancer was able to predict rapid metastatic disease in node-negative, high-risk men managed by radical prostatectomy without adjuvant therapy in a recently published study.